HIF1A and neoplasm: We considered it necessary to test the efficacy of NPs to deliver HIF-1α siRNA2 to solid tumors in vivo with the goal of assessing whether it was possible to downregulate HIF-1 and its downstream oncogenic genes in a complex and heterogeneous tumor microenvironment.